What's new

Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised

May 16, 2025 - 14:18
 0
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Accofil, filgrastim, D...

Next Article

Human medicines European public assessment report (EPAR): Bortezomib Hospira, bo...

Related Posts

Human medicines European public assessment report (EPAR): Matever, levetiracetam, Date of authorisation: 03/10/2011, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0

European Shortages Monitoring Platform (ESMP): Implemen...

May 13, 2025  0

Product Management Services (PMS) - Implementation of I...

May 6, 2025  0